Corbus Pharmaceuticals Holdings, Inc.
CRBP · Pharmaceutical Preparations · 18.5M shares · +39%/yr ↑ shares · EDGAR filings ↗
Reference price $7.91 · est. market cap ~$147M — last insider sale, 2026-06-10 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D44Clinical/early-stage biotech — oncology/obesity clinical, well-funded.
Strengths
- Liquidity — current ratio 8.1 (73rd)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- High convictionHigh conviction — notable institutional holders, insider buying, and a strong balance sheet
- RestatementPension Matching Contribution Company Health Savings Account Matching Contribution Company-Paid Group Term Life Insurance Premiums Company-Paid Internet Allowance Total All Other Compensat 8-K ↗
- Exec changeRecent 8-K item 5.02 8-K ↗
- Cash burnNegative free cash flow (-64.5M)
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Strong balance sheetStrong balance sheet — $163M cash & investments, ~10 quarters of runway
- Insider buyingInsider buying — 2 open-market buy(s) by 1 insider(s) (~$101,218, last 6mo) Form 4 ↗
- Insider sellingInsider selling — 9 open-market sale(s) by 7 insider(s) (cluster of 7 insiders, ~$320,614, last 6mo) Form 4 ↗
- Notable holderHeld by 5 notable fund(s): CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC +2 more (as of 2026-03-31)
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Return on equity
-53.2%
Return on assets
-46.7%
Current ratio
8.1×
Free cash flow
-$64M
EBITDA
-$85M
Tangible book value
$148M
Cash & investments
$163M
Cash runway
10q
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-10 | Jenkins John Kenneth | Sell | 4.8K | $7.91 |
| 2026-06-10 | Altmeyer Anne | Sell | 2.4K | $7.91 |
| 2026-06-10 | Kung Winston | Sell | 2.0K | $7.91 |
| 2026-06-03 | Saxena Nishant C | Buy | 9.0K | $7.58 |
| 2026-06-02 | Saxena Nishant C | Buy | 4.5K | $7.33 |
| 2026-05-21 | Saxena Nishant C | Grant | 58K | — |
| 2026-05-19 | Pfeiffenberger Brent | Grant | 7.5K | — |
| 2026-05-19 | Kung Winston | Grant | 3.8K | — |
| 2026-05-19 | Jacques Rachelle Suzanne | Grant | 3.8K | — |
| 2026-05-19 | Jenkins John Kenneth | Grant | 3.8K | — |
| 2026-05-19 | Altmeyer Anne | Grant | 3.8K | — |
| 2026-05-19 | Ben Yong | Grant | 3.8K | — |
| 2026-03-02 | Smethurst Dominic | Sell | 6.1K | $8.30 |
| 2026-02-17 | Hodgson Ian | Sell | 847 | $7.38 |
| 2026-02-13 | Moran Sean F. | Sell | 4.7K | $7.78 |
| 2026-02-13 | Cohen Yuval | Sell | 14K | $7.78 |
| 2026-02-03 | Smethurst Dominic | Sell | 3.3K | $8.09 |
| 2026-02-03 | Hodgson Ian | Sell | 2.4K | $8.09 |
| 2026-01-14 | Hodgson Ian | Grant | 28K | — |
| 2026-01-14 | Smethurst Dominic | Grant | 28K | — |
| 2026-01-14 | Moran Sean F. | Grant | 28K | — |
| 2026-01-14 | Cohen Yuval | Grant | 50K | — |
| 2025-12-11 | Cormorant Asset Management, LP | Sell | 30K | $11.46 |
| 2025-10-27 | Cohen Yuval | Sell | 9.0K | $17.14 |
| 2025-10-27 | Cohen Yuval | Option exercise | 9.0K | $4.26 |
| 2025-10-24 | Moran Sean F. | Option exercise | 13K | $4.26 |
| 2025-10-24 | Moran Sean F. | Sell | 13K | $17.02 |
| 2025-10-24 | Cohen Yuval | Sell | 19K | $17.01 |
| 2025-10-24 | Cohen Yuval | Option exercise | 19K | $4.26 |
| 2025-10-20 | Altmeyer Anne | Option exercise | 1.1K | $4.80 |
| 2025-10-20 | Altmeyer Anne | Sell | 1.1K | $20.50 |
| 2025-05-30 | Jenkins John Kenneth | Grant | 4.8K | — |
| 2025-05-30 | Kung Winston | Grant | 4.8K | — |
| 2025-05-30 | Ben Yong | Grant | 4.8K | — |
| 2025-05-30 | Jenkins John Kenneth | Sell | 2.8K | $7.35 |
| 2025-05-30 | Altmeyer Anne | Sell | 1.4K | $7.25 |
| 2025-05-30 | Altmeyer Anne | Grant | 4.8K | — |
| 2025-05-30 | HOLMER ALAN F | Grant | 4.8K | — |
| 2025-05-30 | Jacques Rachelle Suzanne | Grant | 4.8K | — |
| 2025-03-06 | Smethurst Dominic | Sell | 6.4K | $6.78 |
| 2025-02-14 | Moran Sean F. | Sell | 2.8K | $8.76 |
| 2025-02-14 | Cohen Yuval | Sell | 7.1K | $8.76 |
| 2025-01-31 | Smethurst Dominic | Grant | 27K | — |
| 2025-01-31 | Moran Sean F. | Grant | 28K | — |
| 2025-01-31 | Cohen Yuval | Grant | 68K | — |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-05-26 | Reg FDOtherExhibits | filing ↗ |
| 2026-05-21 | Material agreementExec/director changeReg FDExhibits | filing ↗ |
| 2026-05-14 | Exec/director changeShareholder voteReg FDExhibits | filing ↗ |
| 2026-05-12 | ResultsReg FDExhibits | filing ↗ |
| 2026-04-16 | Exec/director changeExhibits | filing ↗ |
| 2026-04-14 | Reg FDOtherExhibits | filing ↗ |
| 2026-04-07 | Exec/director changeReg FDOtherExhibits | filing ↗ |
| 2026-03-09 | ResultsReg FDExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-05-26 | 2026-05-26 | 0001193125-26-238059 ↗ |
| 8-K | 2026-05-21 | 2026-05-19 | 0001193125-26-233507 ↗ |
| 8-K | 2026-05-14 | 2026-05-13 | 0001193125-26-222890 ↗ |
| 10-Q | 2026-05-12 | 2026-03-31 | 0001193125-26-219707 ↗ |
| 8-K | 2026-05-12 | 2026-05-12 | 0001193125-26-218250 ↗ |
| 8-K | 2026-04-16 | 2026-04-15 | 0001193125-26-159062 ↗ |
| 8-K | 2026-04-14 | 2026-04-14 | 0001193125-26-153923 ↗ |
| 8-K | 2026-04-07 | 2026-04-01 | 0001193125-26-144588 ↗ |
| 8-K | 2026-03-09 | 2026-03-09 | 0001193125-26-097582 ↗ |
| 10-K | 2026-03-09 | 2025-12-31 | 0001193125-26-098530 ↗ |
| 8-K | 2026-02-25 | 2026-02-25 | 0001193125-26-068566 ↗ |
| 8-K | 2026-01-12 | 2026-01-12 | 0001193125-26-009758 ↗ |